#cerapedics Archives - Orthopedics This Week

Legal & Regulatory and Reimbursement

FDA Expands Indications for iFactor Use in Spine Surgery

by Kim DelMonico October 18, 2024November 13, 2024

Cerapedic’s Inflection Point

by Robin Young August 2, 2023November 6, 2023

New Cost Effectiveness Data for Bone Growth Peptide

by Elizabeth Hofheinz, M.P.H., M.Ed. September 7, 2021October 24, 2024

Spine

P-15 Peptide or BMP-2? Both PMA Approved. One Has Clear Advantages

by Adam Suhy, Ph.D. July 13, 2021March 14, 2025

Legal & Regulatory and Reimbursement

Cerapedics’ Newest Biologic Now Available in Canada

by Adam Suhy, Ph.D. November 13, 2020November 1, 2024

Legal & Regulatory and Reimbursement

Cerapedics’ Next-Generation Graft Approved by Health Canada

by Adam Suhy, Ph.D. September 28, 2020November 1, 2024

Spine

With a Recent FDA Ruling, Cerapedics Takes Aim at Infuse

by Adam Suhy, Ph.D. August 20, 2020October 24, 2024

Amino Peptide Bone Graft Beats Allograft in New Study

by Adam Suhy, Ph.D. May 26, 2020November 1, 2024

Legal & Regulatory and Reimbursement

Additional FDA Approval for Cerapedics i-FACTOR Bone Graft

by Walter Eisner December 3, 2019November 1, 2024

Cerapedics Expands Headquarters, Workforce

by Elizabeth Hofheinz, M.P.H., M.Ed. July 29, 2019November 1, 2024

Spine

Cerapedics: First Patients Enrolled in Bone Graft Trial

by Elizabeth Hofheinz, M.P.H., M.Ed. August 2, 2018November 1, 2024

$22 Million for Cerapedics

by Elizabeth Hofheinz, M.P.H., M.Ed. July 26, 2018November 1, 2024

Cerapedics Receives 2018 MedTech Breakthrough Award

by Tracey Romero June 25, 2018November 1, 2024

Market Analysis and Forecast, Spine

Q1 2017: Spine Market Analysis and Forecast

by Robin Young April 24, 2017August 2, 2017